Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Rani Therapeutics Holdings, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19
Revenues0.036.62.72.70.51.0
            Revenue growth-100.0%1247.3%488.1% -52.8% 
Cost of goods sold0.063.50.054.30.028.0
Gross profit0.0-26.82.7-51.60.5-27.1
            Gross margin -73.3%100.0%-1899.1%100.0%-2764.6%
Research and development36.6 26.5 12.0 
General and administrative26.826.827.827.85.03.5
EBIT-63.5-63.5-51.6-51.6-16.5-27.1
            EBIT margin -173.3%-1899.1%-1899.1%-3581.0%-2764.6%
Pre-tax income-63.3-63.3-53.0-53.0-16.7-26.6
Income taxes0.10.10.00.00.00.0
            Tax rate     0.0%
Net income-30.6-63.3-8.3-53.10.00.0
            Net margin -173.0%-306.6%-1953.9%0.0%0.0%
 
Diluted EPS($1.28) ($0.43)   
Shares outstanding (diluted)23.8 19.5   
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy